YES, you read that right! Umbrella Labs is now offering SEMAGLUTIDE TABLETS in 7mg and 14 mg. I am still in shock myself seeing this! This is, as usual, on another level but we have come to expect that from Umbrella Labs! I was able to get my hands on a dosing protocol as well! Very revolutionary to say the least!! Right on time for black Friday and perfect timing to overcome the inevitable bad holiday diets! Here is the link to get them along with the dosing protocol
SEMAGLUTIDE PEPTIDE 2MG/5MG/10MG VIAL
Semaglutide Peptide CAS Number 910463-68-2 Other Names GLP-1 Analogue, Ozempic, Rybelsus, NN9535, Wegovy, UNII-53AXN4NNHX, NN 9535, NNC 0113-0217, 53AXN4NNHX, Semaglutida IUPAC Name...
umbrellalabs.is
Semaglutide Tablets Dosage Protocol
Week 1–4: Starting Dose
• Dose: 7mg once every 2 days
• Instructions: Take at least 30 minutes before the first food, drink, or any other oral medication of the day. Use water to swallow the tablet, and avoid splitting or crushing it.
• Purpose: To allow the body to gradually adjust to the medication and reduce the risk of side effects like nausea or GI discomfort.
Week 5–8: Maintenance Dose Adjustment
• Dose: Increase to 7mg once daily if tolerated.
• Instructions: Continue taking on an empty stomach at least 30 minutes before eating or drinking. Do not crush or split tablet.
• Purpose: Increase effectiveness in managing blood glucose levels or weight, based on the patient’s goals and tolerability.
Week 9 and Beyond: Full Dose (if necessary and as tolerated)
• Dose: Increase to 14 mg once daily or every two days, based on therapeutic goals and if previous doses are well-tolerated.
• Instructions: Follow the same guidelines regarding timing and intake. Never crush or split tablets
• Purpose: Achieve optimal therapeutic effects for glucose control and/or weight loss, as determined by a healthcare provider.
Key Considerations
• Adherence: Take semaglutide consistently at the same time each day.
• Monitoring: Regularly monitor blood glucose (for diabetic patients) and watch for side effects like nausea, vomiting, or abdominal discomfort, which are common with GLP-1 receptor agonists.
• Adjustment: If adverse effects persist or are severe, consult a healthcare provider for a potential dosage adjustment or extended titration period.
